Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Children's immune system better prepared to defend against SARS-CoV-2, study finds

Why are severe courses of SARS-CoV-2 infection much less common in children and adolescents than in adults? Scientists at the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) have now discovered that the immune system in the upper respiratory tract is much more alert and active in children before infection than in adults and is therefore better equipped to fight the virus.

18 Oct 2023

Shaping the Future of Therapeutics with 3D Imaging Mass Cytometry

In this interview conducted at SLAS EU 2023 in Brussels, Belgium, we spoke to Laura Kuett, a Ph.D. student in Systems Biology, about the promise of 3D Imaging Mass Cytometry.

17 Oct 2023

Bats' genes hold secrets to stronger immunity and longer life

Bats have acquired remarkable traits throughout their evolution. They're the only mammals that can fly, and they live much longer than other animals their size.

16 Oct 2023

Antibiotic-resistant bacteria in Ghana confined to clinical settings

Calland, J. K., et al. (2023). Population structure and antimicrobial resistance among Klebsiella isolates sampled from human, animal, and environmental sources in Ghana: a cross-sectional genomic One Health study. The Lancet Microbe. doi.org/10.1016/S2666-5247(23)00208-2.

16 Oct 2023

Medicare enrollees can switch coverage now. Here’s what’s new and what to consider.

Consumers know it's fall when stores start offering Halloween candy and flu shots — and airwaves and mailboxes are filled with advertisements for Medicare options.

16 Oct 2023

New mRNA flu vaccine shows promise: Faster to produce, highly effective in mice

The study evaluates the efficacy of a new quadrivalent mRNA influenza vaccine, finding it to be highly immunogenic and protective in a mouse model. Compared to traditional vaccines, the mRNA-based option offers advantages like reduced production time and elimination of the risk of growth-promoting mutations.

15 Oct 2023

Is it time to rethink COVID-19 boosters? New study dives into variant-specific vaccines

The study explores the efficacy of variant-adapted COVID-19 booster vaccines, particularly against new strains like Omicron. It raises questions about the need for annual updates and the best technologies for long-term, durable immunity.

15 Oct 2023

Early and severe: Kids hit hard by 2022-23 flu season, vaccination rates drop

The 2022-23 influenza season saw a highly severe impact on U.S. adolescents and children, with early peaks in hospitalization rates and outpatient visits. The study underscores the importance of flu vaccination and antiviral treatment, especially as fewer hospitalized children were vaccinated compared to previous seasons.

15 Oct 2023

Are people with HIV at a higher risk of severe COVID-19 outcomes?

The research review indicates that people with HIV, especially those with low CD4 cell counts, face greater risks of severe COVID-19 outcomes and have suboptimal immune responses to SARS-CoV-2. Antiretroviral therapy aids in clearing infections, and a third vaccine dose reduces the risk of breakthrough infections among this population.

15 Oct 2023

Long-term lung issues and lower quality of life plague COVID-19 survivors, new study warns

New research in Scientific Reports reveals that COVID-19 survivors, especially those who had severe or critical illness, face long-term lung complications and a reduced quality of life. The study recommends 6-monthly pulmonary function tests for these survivors to monitor for chronic lung damage.

15 Oct 2023

Newly discovered synthetic adjuvant materials could make vaccines more accessible, sustainable

New raw vaccine materials that could make vaccines more accessible, sustainable, and ethical have been discovered.

14 Oct 2023

New insights into coronavirus E channel could lead to antiviral drugs

The genome of the SARS-CoV-2 virus encodes 29 proteins, one of which is an ion channel called E. This channel, which transports protons and calcium ions, induces infected cells to launch an inflammatory response that damages tissues and contributes to the symptoms of Covid-19.

13 Oct 2023

Hackensack University Medical Center establishes new Center for Weight Loss and Metabolic Health

Hackensack University Medical Center has established the Center for Weight Loss and Metabolic Health, an integrated program to help people who have struggled to lose weight to achieve and maintain their weight loss goals.

13 Oct 2023

The new vaccines and you: Americans better armed than ever against the winter blechs

Last year's "triple-demic" marked the beginning of what may be a new normal: a confluence of respiratory infections — RSV, influenza, and covid-19 — will surge as the weather cools each year.

13 Oct 2023

Moderna's updated COVID-19 vaccine for Autumn 2023 outperforms in cost and clinical impact

Moderna's updated mRNA-1273.815 COVID-19 vaccine shows promising results in reducing symptomatic cases, hospitalizations, and deaths in high-risk and older adults in Germany. The study finds the vaccine to be more cost-effective and clinically beneficial than both no vaccination and Pfizer's XBB.1.5 BNT162b2 vaccine.

12 Oct 2023

IL-17: The molecule that could revolutionize autoimmune and cancer treatments

The research paper explores the multifaceted role of the IL-17 family in immune response, covering everything from infection control to pathological conditions like autoimmune diseases and cancer. Future therapies may exploit IL-17's unique signaling pathways to offer more targeted and cost-effective treatments.

12 Oct 2023

EVScape: New tool to forecast which SARS-CoV-2 variants could dodge our immunity

Researchers have developed EVScape, a predictive tool that identifies which SARS-CoV-2 strains are most likely to evade host immunity. Utilizing a deep generative model and structural information, the tool offers early warning about viral variants, aiding in the timely development of effective vaccines and treatments.

12 Oct 2023

Genetic causes of Raynaud’s phenomenon identified

Researchers at Queen Mary University of London’s Precision Healthcare Research Institute (PHURI) and the Berlin Institute of Health (BIH) at Charité – Universitätsmedizin Berlin have identified the genetic causes of Raynaud’s phenomenon. Their findings, published today (12 October) in Nature Communications, could lead to the first effective treatments for people with Raynaud’s.

12 Oct 2023

Elderly and vulnerable people at risk from low home temperatures, warns Lilli

Interventions are needed to urgently prevent elderly and vulnerable people from putting their health at risk, with temperatures inside some homes reaching as low as 5C last winter, says Lilli, the SaaS company using a proactive care lifestyle monitoring technology to revolutionise care.

12 Oct 2023

OrganaBio launches new division to meet growing demand for decentralized clinical trial support

OrganaBio, the Contract Technology Development and Manufacturing Organization (CTDMO) specializing in solutions for cell and immunotherapy development, today announces the official launch of Cell Processing and Cryopreservation (CPC) Services, a new division of OrganaBio.

12 Oct 2023

Previous
1
...
59
60
61
62
63
64
65
...
1184
Next

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Children's immune system better prepared to defend against SARS-CoV-2, study finds

Shaping the Future of Therapeutics with 3D Imaging Mass Cytometry

Bats' genes hold secrets to stronger immunity and longer life

Antibiotic-resistant bacteria in Ghana confined to clinical settings

Medicare enrollees can switch coverage now. Here’s what’s new and what to consider.

New mRNA flu vaccine shows promise: Faster to produce, highly effective in mice

Is it time to rethink COVID-19 boosters? New study dives into variant-specific vaccines

Early and severe: Kids hit hard by 2022-23 flu season, vaccination rates drop

Are people with HIV at a higher risk of severe COVID-19 outcomes?

Long-term lung issues and lower quality of life plague COVID-19 survivors, new study warns

Newly discovered synthetic adjuvant materials could make vaccines more accessible, sustainable

New insights into coronavirus E channel could lead to antiviral drugs

Hackensack University Medical Center establishes new Center for Weight Loss and Metabolic Health

The new vaccines and you: Americans better armed than ever against the winter blechs

Moderna's updated COVID-19 vaccine for Autumn 2023 outperforms in cost and clinical impact

IL-17: The molecule that could revolutionize autoimmune and cancer treatments

EVScape: New tool to forecast which SARS-CoV-2 variants could dodge our immunity

Genetic causes of Raynaud’s phenomenon identified

Elderly and vulnerable people at risk from low home temperatures, warns Lilli

OrganaBio launches new division to meet growing demand for decentralized clinical trial support

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Leveraging the Radian ASAP in standard casework

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Leveraging the Radian ASAP in standard casework

Newsletters you may be interested in